Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Enterprise value to sales ratio
Latest
0.00
↓ 100% vs avg
Percentile
P17
Within normal range
Average
2.02
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | - |
| 2024 | 0.00 | +100.0% |
| 2023 | -45.68 | -1482.9% |
| 2022 | 3.30 | -79.5% |
| 2021 | 16.13 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | -100.0% |
| 2018 | 34.34 | +158.9% |
| 2017 | 13.26 | +1290.8% |
| 2016 | -1.11 | - |